← Back to all trials
Recruiting
NCT03910569
The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Conditions: Takotsubo Cardiomyopathy
Sex: All
Ages: 18 Years – N/A
Enrollment: 1000
Sponsor: Cedars-Sinai Medical Center
Location: Cedars Sinai Medical Center Los Angeles California
Summary
The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria of Takotsubo Registry protocol. Subjects will also be invited to provide a blood sample utilizing a Mitra kit sent to their homes. Researchers from the Barbra Streisand Women's Heart Center will analyze Registry data to identify Takotsubo phenotypes, improve diagnostic capabilities, better predict recurrence rates, and develop targeted Takotsubo treatments.
Eligibility Criteria
Inclusion Criteria:
* Have received a diagnosis of Takotsubo from their physician and consent to enroll
* Submit full medical records needed for Takotsubo adjudication
Exclusion Criteria:
* Younger than 18 years
* Unable to provide informed consent
* Unable to provide the necessary documentation needed for screening purposes
Source: ClinicalTrials.gov (NCT03910569). StuddyBuddy aggregates publicly available trial information.
